sulfamethoxazole has been researched along with Encephalopathy, Hepatic in 2 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Finlayson, WB | 1 |
| Johnson, G | 1 |
| Horák, J | 1 |
| Mertl, L | 1 |
| Hrabal, P | 1 |
2 other studies available for sulfamethoxazole and Encephalopathy, Hepatic
| Article | Year |
|---|---|
Multisystem toxicity after co-trimoxazole.
Topics: Acute Kidney Injury; Aged; Anuria; Drug Combinations; Drug Eruptions; Female; Hepatic Encephalopathy | 1978 |
[Acute liver failure and severe cholestasis due to sulfonamides].
Topics: Adult; Chemical and Drug Induced Liver Injury; Cholestasis; Drug Combinations; Female; Hepatic Encep | 1985 |